Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999; 96:272–277. , , , .
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol 2003; 77:291–300. , , , , , , , .
et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000; 14:1761–1765. , ,
Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708–11717. , , , , , , .
et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003; 279:17–31. , ,
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 2007; 81:5460–5471. , , , , , , .
HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997; 185:293–303. , , , , , .
et al. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 2000; 14:1911–1915. , ,
et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1- resistant prostitutes in Nairobi. J Immunol 2000; 164:1602–1611. , ,
Evaluation of the cervical cytobrush sampling technique for the preparation of CD45+ mononuclear cells from the human cervix. J Immunol Methods 2001; 258:37–46. , , .
et al. T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr 2007; 44:292–298. , ,
et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of HPV-infected women: Influence of HIV-1 coinfection. Diagn Mol Pathol 2005; 14:39–47. , ,
et al. Negative mucosal synergy between HSV-2 and HIV in the female genital tract. AIDS 2007; 21:589–598. , ,
Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73:1253–1263. , , .
The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 1996; 10:759–764. , , , .
Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995; 7:568–574. , , , , , , .
Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000; 181:939–945. , , , , , .
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86:2336–2340. , , .
Activated CD34-derived Langerhans cells mediate traninfection with Human Immunodeficiency Virus. J Virol 2007; 81:6858–6868. , , , , , .
et al. Impact of mucosal inflammation on cervical HIV-1-specific CD8 T cell responses in the female genital tract during chronic HIV infection. J Virol 2008; 82:8529–8536. , ,
et al. Mucosal T cell responses to HPV type 16 in women with HPV-associated CIN. Immunology 2006; 119:507–14. , ,
Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 1996; 124:757–762. , , , , , , , .
Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect 2004; 80:108–112. , , , , , .
et al. Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327–332. , ,
Impact of elevated inflammatory cytokines in the female genital tract on CD4 destruction during acute HIV-1 infection. J Infect Dis 2008; 198:710–14. , , , , , , , .
et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis 1999; 29:1145–1150. , ,
Interrelationships among HIV-1 infection, bacterial vaginosis, trichomoniasis and the presence of yeasts. J Infect Dis 2002; 185:69–73. , , .
Gynecologic infections in HIV-infected women. Clin Infect Dis 2000; 31:1225–1233. .
Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 2008; 24:667–671. , , , , , , , .
T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997; 185:2089–2094. , , .
Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis 2000; 181:76–81. , , , , , , .
et al. Changes in sexual behaviour and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20:85–92. , ,
Sexual and reproductive behaviour of women with HIV infection. Clin Obstet Gynaecol 2001; 44:289–299. .
Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infection. Sex Transm Dis 2004; 31:100–113. , , , .
Comparison of genital HIV-1 shedding and sexual risk behaviour among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines. J Acquir Immune Defic Syndr 2006; 41:611–615. , , , , , , , .
Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001; 357:432–435. , , , , .
Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect 2001; 77:4–11. , .
Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr HIV/AIDS Rep 2007; 4:80–85. , .
Heterosexual HIV transmission. Infect Agents Dis 1995; 4:273–284. , .
Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994; 56:672–686. .
Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6:173–182. .
HIV and inflammation. Curr HIV Res 2005; 3:243–259. , , , .
Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study. Eur J Obstet Gynecol Reprod Biol 1998; 81:277–282. , , , , .
Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis 2005; 192:728–738. , , , , , , , .
et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417:95–98. , , ,
et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749–759. , , ,
et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112–116. , ,
et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169–180. , ,
et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006; 80:8236–8247. , ,
Mucosal effector memory T cells: the other side of the coin. Cell Mol Life Sci 2005; 62:2853–2866. , .
Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745–763. , , .